−0.005AUD
−7.79 MAUD
5.96 KAUD
About NEUROTECH INTERNATIONAL LIMITED
Sector
Industry
Headquarters
Nedlands
Website
Founded
2016
ISIN
AU000000NTI9
FIGI
BBG00DSXRN99
Neurotech International Ltd. engages in the research, design, development, and manufacture of medical devices and solutions in Australia. Its product includes Mente Autism for the diagnosis and treatment of autism. The company was founded on January 15, 2016 and is headquartered in Nedlands, Australia.
$NTI NTI
--1 year accumulation/consolidation range
--Potential bull pennant forming.
--Hidden Weekly divergence
watch list for now.. looking for a break in direction A or B what direction do you have and why ??
-Landmark study into paediatric ASD (autism spectrum disorder) has now progressed to the t
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of NTI is 0.10 AUD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange NEUROTECH INTERNATIONAL LIMITED stocks are traded under the ticker NTI.
Yes, you can track NEUROTECH INTERNATIONAL LIMITED financials in yearly and quarterly reports right on TradingView.
Like other stocks, NTI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NEUROTECH INTERNATIONAL LIMITED stock right from TradingView charts — choose your broker and connect to your account.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NEUROTECH INTERNATIONAL LIMITED EBITDA is −8.22 M AUD, and current EBITDA margin is −151.31 K%. See more stats in NEUROTECH INTERNATIONAL LIMITED financial statements.